Paul Saladino· MD
what they basically show is that about 45% of these people don't actually show cardiovascular CAC score greater than zero
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what they basically show is that about 45% of these people don't actually show cardiovascular CAC score greater than zero
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so the people's average ldlc while they were on treatment for the high lipids was 158 milligrams per deciliter they said among these nine studies representing these 1,176 asymptomatic uh heterozygous uh Familia hyperia patients the mean pooled prevalence of CAC equal to zero was 45%